Covance Pushes Further into Biologics Development, Lead Optimization

20-May-2013 - Although preclinical work for CROs has fallen flat in recent quarters, Covance is looking to take advantage of the industry’s shift to early biologic developments and lead optimization.

UK ‘animal research’ labelling plan may have unintended consequences says Cyprotex

16-May-2013 - Proposed UK “animal research” labelling laws may backfire if improvements in culture-based toxicology testing continue, according to in vitro CRO Cyprotex. 

Former RPS CIO's Lawsuit Claims Wrongful Termination

14-May-2013 - Research Pharmaceutical Services' (RPS) former chief information officer (CIO) claims he was unfairly dismissed after discovering the CRO was unlawfully storing potential employees' personal data.

Derma Acquisitions and Need for Development Drive MedPharm Investment

07-May-2013 - MedPharm has opened a new laboratory in response to high demand for its preclinical dermatological services.

Icon Beats Expectations in Q1, Sees Unexpected Uptick in Revenue Growth

29-Apr-2013 - Icon’s first quarter FY2013 revenue increased 26% year on year, besting analysts’ expectations and resulting in a nearly 7% increase in the company’s stock price.

News in brief

Ex-Aptuit Employee Gets Jail Time for Manipulation of Trial Data

18-Apr-2013 - A man has been given a custodial sentence by a court in Edinburgh, UK after being found guilty of altering preclinical trial data.

Update

Covance's Asia Focus Sees Expansion in Singapore Services

16-Apr-2013 - Covance says anticipated future demand across the Asia Pacific region drove the latest expansion of its services in Singapore.

CROs Face Stagnant Preclinical Market Growth

10-Apr-2013 - An uptick in the outsourcing of preclinical trials is expected as pharmaceutical companies look to restructure and cut costs, but that increase won't necessarily begin in 2013, according to an analyst.

Client Demand Pushes Early Phase Australian CRO to Expand to Large Molecules

10-Apr-2013 - Early phase clinical trial provider CPR Pharma Services has expanded its bioanalytical offerings with a ligand-binding assay service for its clients developing large molecules such as biologics, monoclonal antibodies and...

Crown and Horizon Team on Preclinical Model Development for Personalized Meds

10-Apr-2013 - Crown Bioscience and Horizon Discovery have teamed up to develop more accurate preclinical models for the development of personalized medicines.

Preclinical CRO Pushes into India to Reduce Human Bioequivalence Studies

10-Apr-2013 - Preclinical CRO Absorption Systems has partnered with Indian consulting firm Synerzys Lifecare to promote the benefits of BCS testing to the country's generic drugmakers.

CRO Pays $22.5M to Dr. Reddy’s to Settle Lawsuit

26-Mar-2013 - Canada-based CRO Nordion paid $22.5 million last week to settle a lawsuit by Dr. Reddy’s Laboratories claiming Nordion breached its lab services agreement.

Price of Life Tech Steady at $11B as Roche Joins Bidding War Set for April

25-Mar-2013 - Bidders for DNA-sequencing equipment maker Life Technologies may not have to pay too much more than its current market value of $64 per share, or about $11B, according to an...

AstraZeneca R&D rejig will impact commercial and manufacturing ops

19-Mar-2013 - The ‘R&D’ reorganisation announced by AstraZeneca yesterday will impact manufacturing and commercial operations as well drug development activities.

Preclinical Data Fraud is 'Rare' says UK MHRA and Rule Rejig Not Needed

19-Mar-2013 - Fraudulent manipulation of preclinical trial data is rare and the regulations that cover this type of research do not need to be revised according to the UK MHRA.

CRO Group Says More Reductions in UK Early Phase Research Likely

19-Mar-2013 - The UK’s CCRA (Clinical Contract Research Association) says the number of Phase 1 clinical trials in the UK has “decreased substantially” since 2003 and is likely to be further diminished...

Calvert Labs, Particle Science Form Preclincial Development Partnership

18-Mar-2013 - Pennsylvania-based Calvert Laboratories and Particle Sciences are combining their expertise in preclinical drug development to provide clients with more streamlined options.

WuXi Expands Antibody Discovery Partnership with Transgenic Animal Developer

07-Mar-2013 - WuXi PharmaTech has expanded its partnership with Open Monoclonal Technology (OMT) to use its transgenic rats and mice in China and other Asian countries.

Chinese CRO Partnerships Focus on Bioavailability, PK/PD Analysis

04-Mar-2013 - Contract drug developer Particle Sciences has recently chosen China-based CRO Crystal Pharmatech to analyse the bioavailability and material properties of its developing compounds, and the collaboration may turn into a...

Icon Beats Q4 Estimates, Prepares for Revenue Uptick in 2013

26-Feb-2013 - Ireland-based CRO Icon unveiled higher than expected revenue and backlog increases in 2012 when compared to 2011, and the company expects even stronger results in 2013.

CiToxLAB Beats Preclinical Market Trends

21-Feb-2013 - CiToxLAB says strong revenue growth in 2012 was due to a new global status following its acquisition of Lab Research.

News in brief

Merck & Co Agrees to $300m Research Contract with Lycera

18-Feb-2013 - Merck & Co and Lycera have signed a preclinical research deal that could be worth up to $300m if certain milestones are met.

PPD Expands Central Lab Services in Brussels, Singapore

14-Feb-2013 - PPD has expanded its central lab testing services at its Brussels and Singapore labs and will offer additional services in microbiology, peripheral blood mononuclear cell and molecular pathology services.

GenScript plays piper bringing transgenic rats to Asia

29-Jan-2013 - GenScript says the chance to expand into Asia is the drive for taking its drug delivery platform out on the road.